在中:预测HLA类I限制新抗原的内在特征
Ting Sun1, Beibei Xin1,2, Yubo Fan1
1Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Centre for Biomedical Engineering, School of Engineering Medicine & School of Biological Science and Medical Engineering, Beihang University, Haidian District, Beijing, People's Republic of China.
Methods in molecular biology (Clifton, N.J.)
|June 22, 2024
概括
本研究介绍了GNIFdb,这是一个关于质瘤新抗原及其特征的数据库. GNIFdb有助于识别新抗原候选物和预测质母细胞瘤患者的存活率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物信息学是一种生物信息学.
背景情况:
- 来自瘤突变的新抗原具有对预测免疫性和患者生存至关重要的内在特征.
- 质瘤,特别是质母细胞瘤,由于瘤异质性和抵抗机制,在治疗中存在挑战.
研究的目的:
- 引入瘤新抗原内在特征数据库 (GNIFdb).
- 为计算新抗原特征和预测质瘤患者的整体存活率提供工具.
- 为了促进对治疗策略的潜在新抗原候选人的识别.
主要方法:
- 计算预测的HLA-I受限新抗原,特定于质瘤的新抗原被策划.
- 描述了这些新抗原的内在特征,包括氨基酸描述物和物理化学性质.
- 用于特征计算和整体生存预测的工具被整合到GNIFdb中.
主要成果:
- GNIFdb收藏了一系列关于质瘤新抗原及其内在特征的综合资料.
- 该数据库可以识别潜在的新抗原候选者,以质母细胞瘤中的ATF6为例.
- 综合工具在预测初级IDH野生型质母细胞瘤的总生存率方面表现出实用性.
结论:
- GNIFdb 作为一种宝贵的资源,用于质瘤新抗原研究.
- 内在特征分析和预测工具可以增强免疫疗法策略和患者分层.
- 该数据库支持在质瘤中发现新的治疗点和生物标志物.
相关概念视频
Antigens Involved in Adaptive Immunity
483
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
483
Antigen Processing Pathways
989
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
989


